Fort Washington Investment Advisors Inc Amgen Inc Transaction History

Fort Washington Investment Advisors Inc

$15 Billion
Q2 2024

A detailed history of Fort Washington Investment Advisors Inc transactions in Amgen Inc stock. As of the latest transaction made, Fort Washington Investment Advisors Inc holds 65,748 shares of AMGN stock, worth $21.1 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

65,748

Previous 1,979 3222.28%

Holding current value

$21.1 Million

Previous $562,000 3555.16%

% of portfolio

0.14%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	BUY	$262.75 - $319.31 $16.8 Million - $20.4 Million	63,769 Added 3222.28%	65,748 $20.5 Million
Q4 2023 Jan 17, 2024	SELL	$255.7 - $288.46 $2,557 - $2,884	-10 Reduced 0.5%	1,979 $569,000
Q3 2023 Nov 07, 2023	SELL	$218.65 - $271.46 $23,395 - $29,046	-107 Reduced 5.1%	1,989 $534,000
Q4 2022 Jan 30, 2023	SELL	$229.03 - $291.01 $6,412 - $8,148	-28 Reduced 1.32%	2,096 $550,000
Q2 2022 Aug 05, 2022	BUY	$230.71 - $256.74 $5,998 - $6,675	26 Added 1.24%	2,124 $517,000
Q4 2021 Feb 07, 2022	SELL	$198.88 - $227.6 $46,140 - $52,803	-232 Reduced 9.96%	2,098 $472,000
Q1 2021 May 05, 2021	SELL	$221.91 - $258.6 $953,769 - $1.11 Million	-4,298 Reduced 64.85%	2,330 $580,000
Q4 2020 Feb 03, 2021	SELL	$216.38 - $257.67 $3.27 Million - $3.9 Million	-15,121 Reduced 69.53%	6,628 $1.52 Million
Q3 2020 Nov 10, 2020	SELL	$234.65 - $260.95 $5.77 Million - $6.41 Million	-24,581 Reduced 53.06%	21,749 $5.53 Million
Q2 2020 Jul 31, 2020	SELL	$197.81 - $242.74 $2.04 Million - $2.5 Million	-10,313 Reduced 18.21%	46,330 $10.9 Million
Q1 2020 May 06, 2020	SELL	$182.24 - $241.7 $3.45 Million - $4.58 Million	-18,937 Reduced 25.06%	56,643 $11.5 Million
Q4 2019 Feb 03, 2020	SELL	$189.21 - $243.2 $12.3 Million - $15.8 Million	-64,848 Reduced 46.18%	75,580 $18.2 Million
Q3 2019 Nov 08, 2019	BUY	$174.11 - $208.62 $1.96 Million - $2.35 Million	11,267 Added 8.72%	140,428 $27.2 Million
Q1 2019 May 10, 2019	SELL	$180.87 - $203.88 $405,691 - $457,302	-2,243 Reduced 1.71%	129,161 $24.5 Million
Q4 2018 Feb 05, 2019	SELL	$178.4 - $208.25 $1.73 Million - $2.02 Million	-9,715 Reduced 6.88%	131,404 $25.6 Million
Q3 2018 Nov 07, 2018	SELL	$185.29 - $208.89 $1.87 Million - $2.11 Million	-10,110 Reduced 6.69%	141,119 $29.3 Million
Q2 2018 Jul 27, 2018	BUY	$166.05 - $186.51 $24,907 - $27,976	150 Added 0.1%	151,229 $27.9 Million
Q1 2018 May 02, 2018	SELL	$169.43 - $198.0 $1.57 Million - $1.83 Million	-9,237 Reduced 5.76%	151,079 $25.8 Million
Q4 2017 Feb 12, 2018	BUY	$168.79 - $188.59 $17.4 Million - $19.5 Million	103,347 Added 181.41%	160,316 $27.9 Million
Q3 2017 Nov 13, 2017	SELL	$167.29 - $191.0 $154,743 - $176,675	-925 Reduced 1.6%	56,969 $10.6 Million
Q2 2017 Aug 10, 2017	BUY	N/A	57,894	57,894 $9.97 Million

Others Institutions Holding AMGN

# of Institutions

3,052

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort Washington Investment Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Fort Washington Investment Advisors Inc with notifications on news.

Account

Fort Washington Investment Advisors Inc Amgen Inc Transaction History